Stericycle Statistics
Total Valuation
Stericycle has a market cap or net worth of $4.62 billion. The enterprise value is $6.36 billion.
| Market Cap | 4.62B |
| Enterprise Value | 6.36B |
Important Dates
The next confirmed earnings date is Thursday, April 25, 2024, before market open.
| Earnings Date | Apr 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Stericycle has 92.57 million shares outstanding.
| Shares Outstanding | 92.57M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 107.13% |
| Float | 92.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 20.88 |
| PS Ratio | 1.74 |
| Forward PS | 1.66 |
| PB Ratio | 1.83 |
| P/FCF Ratio | 41.22 |
| PEG Ratio | 2.25 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.67, with an EV/FCF ratio of 56.82.
| EV / Earnings | n/a |
| EV / Sales | 2.39 |
| EV / EBITDA | 21.67 |
| EV / EBIT | 82.54 |
| EV / FCF | 56.82 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.71.
| Current Ratio | 0.94 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 6.07 |
| Debt / FCF | 15.92 |
| Interest Coverage | 1.04 |
Financial Efficiency
Return on equity (ROE) is -0.90% and return on invested capital (ROIC) is -12.01%.
| Return on Equity (ROE) | -0.90% |
| Return on Assets (ROA) | -0.40% |
| Return on Capital (ROIC) | -12.01% |
| Revenue Per Employee | $196,985 |
| Profits Per Employee | -$1,585 |
| Employee Count | 13,500 |
| Asset Turnover | 0.50 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Stericycle has paid $24.60 million in taxes.
| Income Tax | 24.60M |
| Effective Tax Rate | 768.75% |
Stock Price Statistics
The stock price has increased by +19.10% in the last 52 weeks. The beta is 1.09, so Stericycle's price volatility has been similar to the market average.
| Beta (1Y) | 1.09 |
| 52-Week Price Change | +19.10% |
| 50-Day Moving Average | 51.39 |
| 200-Day Moving Average | 46.92 |
| Relative Strength Index (RSI) | 46.90 |
| Average Volume (30 Days) | 459,206 |
Short Selling Information
The latest short interest is 2.08 million, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 2.08M |
| Short Previous Month | 2.10M |
| Short % of Shares Out | 2.25% |
| Short % of Float | 2.26% |
| Short Ratio (days to cover) | 3.50 |
Income Statement
In the last 12 months, Stericycle had revenue of $2.66 billion and -$21.40 million in losses. Loss per share was -$0.23.
| Revenue | 2.66B |
| Gross Profit | 1.01B |
| Operating Income | 77.30M |
| Pretax Income | 3.20M |
| Net Income | -21.40M |
| EBITDA | 293.60M |
| EBIT | 77.10M |
| Loss Per Share | -$0.23 |
Balance Sheet
The company has $35.30 million in cash and $1.78 billion in debt, giving a net cash position of -$1.75 billion or -$18.88 per share.
| Cash & Cash Equivalents | 35.30M |
| Total Debt | 1.78B |
| Net Cash | -1.75B |
| Net Cash Per Share | -$18.88 |
| Equity / Book Value | 2.52B |
| Book Value Per Share | 27.25 |
| Working Capital | -46.50M |
Cash Flow
In the last 12 months, operating cash flow was $243.30 million and capital expenditures -$131.30 million, giving a free cash flow of $112.00 million.
| Operating Cash Flow | 243.30M |
| Capital Expenditures | -131.30M |
| Free Cash Flow | 112.00M |
| FCF Per Share | $1.21 |
Margins
Gross margin is 38.15%, with operating and profit margins of 2.91% and -0.80%.
| Gross Margin | 38.15% |
| Operating Margin | 2.91% |
| Pretax Margin | 0.12% |
| Profit Margin | -0.80% |
| EBITDA Margin | 11.04% |
| EBIT Margin | 2.90% |
| FCF Margin | 4.21% |
Dividends & Yields
Stericycle does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.33% |
| Shareholder Yield | -0.33% |
| Earnings Yield | -0.46% |
| FCF Yield | 2.43% |
Analyst Forecast
The average price target for Stericycle is $62.25, which is 24.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $62.25 |
| Price Target Difference | 24.83% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 4.49% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 1, 2007. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2007 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Stericycle has an Altman Z-Score of 1.88 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.88 |
| Piotroski F-Score | 6 |